First, absolute incidence: in the pooled STEP 1 to 3 obesity trials of semaglutide 2.4 mg (the Wegovy weight-management dose), constipation affected 24.2% of patients versus 11.1% on placebo , alongside nausea (43.9%), diarrhoea (29.7%), and vomiting (24.5%)
Both scenarios are common, and both are preventable with this formula
A once-weekly compounded semaglutide injection, prescribed by a doctor as part of a personalized treatment plan
Talk to your healthcare provider about dosage Constipation (and other side effects of semaglutide) can happen more frequently at higher doses
People who live with obesity face Semaglutide and phentermine are both popular weight loss drugs, but they are very different
Most people can continue their daily low-dose aspirin regimen while on semaglutide, but it should be done under a doctors supervision